Ryan Martins
CIK 1792018 · Chief Financial Officer · last filed 2025-10-30
Ryan Martins is a Chief Financial Officer who has filed 33 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing, for ETNB, was dated Oct 30, 2025. Across all open-market trades the lifetime net is −$638.8K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ETNB price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
14TH FLOOR
SAN FRANCISCO, CA 94105
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| 89bio, Inc. (ETNB) Delisted | Chief Financial Officer | 374,295 | $14.84 | $5.55M | -$638.8K | 33 | 2025-10-30 |
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-30 | 89bio, Inc. (ETNB) Delisted | Mixed | −339,295 | $0 | EDGAR |
| 2025-10-23 | 89bio, Inc. (ETNB) Delisted | Exer (M) | +80,799 | $256.5K | EDGAR |
| 2025-08-05 | 89bio, Inc. (ETNB) Delisted | Tax (F) | −7,680 | -$70.3K | EDGAR |
| 2025-06-13 | 89bio, Inc. (ETNB) Delisted | Tax (F) | −8,498 | -$81.8K | EDGAR |
| 2025-02-19 | 89bio, Inc. (ETNB) Delisted | Tax (F) | −780 | -$8.2K | EDGAR |
| 2025-02-11 | 89bio, Inc. (ETNB) Delisted | Tax (F) | −3,828 | -$43.7K | EDGAR |
| 2025-02-04 | 89bio, Inc. (ETNB) Delisted | Mixed | +76,662 | -$32.0K | EDGAR |
| 2024-12-16 | 89bio, Inc. (ETNB) Delisted | Grant (A) | −95,000 | $0 | EDGAR |
| 2024-09-10 | 89bio, Inc. (ETNB) Delisted | Tax (F) | −3,212 | -$27.2K | EDGAR |
| 2024-08-19 | 89bio, Inc. (ETNB) Delisted | Tax (F) | −777 | -$6.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.